Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients

Antiviral Abidol is Associated with the Reduction of In-Hospital Mortality in COVID-19 Patients

Abstract. Objective:. Coronavirus disease 2019 (COVID-19) is a global public health crisis. There are no specific antiviral agents for the treatment of SARS-CoV-2. Information regarding the effect of Abidol on in-hospital mortality is scarce. The present study aimed to evaluate the treatment effect...

Full description

Saved in:
Bibliographic Details
Main Authors: Hesong Zeng, Xingwei He, Wanjun Liu, Jing Kan, Liqun He, Jinhe Zhao, Cynthia Chen, Junjie Zhang, Shaoliang Chen, Tianyu Xu, Xiaoxia Fu.
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2021-03-01
Series:Cardiology Discovery
Online Access:http://journals.lww.com/10.1097/CD9.0000000000000014
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items